pharmaceutical sciences سال:2020 - دوره:26

Fa | Ar | En


pharmaceutical sciences
سال:2020 - دوره:26 - شماره:Suppl 1

a summary of coronavirus disease 2019: what we should know? - صفحه:S24-S35 commentary: a rapid strategy for repurposing drugs for covid-19 - صفحه:S91-S93 commentary: dexmedetomidine: an all sedation-in–one drug in critically ill patients with covid-19 - صفحه:S80-S81 commentary: diabetes and the covid-19 pandemic: what should the diabetes patients know? - صفحه:S87-S90 commentary: persistence of sars-cov-2 on the beauty products, their containers’ surfaces, and the possibility of secondary and cross-contamination - صفحه:S84-S86 commentary: plasmapheresis: a new strategy in the treatment of covid-19 - صفحه:S82-S83 commentary: prophylactic use of chloroquine may impair innate immune system response against sars-cov-2 - صفحه:S78-S79 covid-19: clinical characteristics and molecular levels of candidate compounds of prospective herbal and modern drugs in indonesia - صفحه:S12-S23 covid19: a devastating pandemic - صفحه:S3-S11 editorial: higher education system in light of covid-19 - صفحه:S1-S2 in silico drug repurposing of penicillins to target main protease mpro of sars-cov-2 - صفحه:S52-S62 investigational drugs for the covid 19 pandemic – a concise review - صفحه:S36-S48 molecular docking of novel 5-o-benzoylpinostrobin derivatives as sars-cov-2 main protease inhibitors - صفحه:S63-S77 nsaids and covid-19: a new challenging area - صفحه:S49-S51